A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapy.

about

A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapy.

Item

http://www.wikidata.org/entity/Q41718682

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A retrospective review of the ...... gibility for systemic therapy.

@en

type

Item

label

A retrospective review of the ...... gibility for systemic therapy.

@en

prefLabel

A retrospective review of the ...... gibility for systemic therapy.

@en

P1476

A retrospective review of the ...... gibility for systemic therapy.

@en

P2093

Cheryl Ho

http://www.w3.org/2001/XMLSchema#string

Georgia Geller

http://www.w3.org/2001/XMLSchema#string

Janessa Laskin

http://www.w3.org/2001/XMLSchema#string

Winson Y Cheung

http://www.w3.org/2001/XMLSchema#string

P2860

Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties.

Cabozantinib in progressive medullary thyroid cancer.

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.

Medullary thyroid carcinoma: a 30-year experience at one institution in Korea.

Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years.

Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.

Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases.

P2888

s13044-017-0041-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13044-017-0041-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091841157

http://www.w3.org/2001/XMLSchema#string

P698

28932277

http://www.w3.org/2001/XMLSchema#string

P932

5606127

http://www.w3.org/2001/XMLSchema#string